Evidence map›Paper›PMID 35286499›Full record

ArticleMikrochimica acta2022

Binary MoS

Beatriz Arévalo, Marina Blázquez-García, Alejandro Valverde, Verónica Serafín, Ana Montero-Calle, Guillermo Solís-Fernández, Rodrigo Barderas, Susana Campuzano, Paloma Yáñez-Sedeño, José M Pingarrón

Open access · hybridAbstract read
In one paragraph

Article in Mikrochimica acta, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Beatriz ArévaloDepartment of Analytical Chemistry, Faculty of Chemistry, Complutense University of Madrid, 28040, Madrid, Spain.
Marina Blázquez-GarcíaDepartment of Analytical Chemistry, Faculty of Chemistry, Complutense University of Madrid, 28040, Madrid, Spain.
Alejandro ValverdeDepartment of Analytical Chemistry, Faculty of Chemistry, Complutense University of Madrid, 28040, Madrid, Spain.
Verónica SerafínDepartment of Analytical Chemistry, Faculty of Chemistry, Complutense University of Madrid, 28040, Madrid, Spain.
Ana Montero-CalleChronic Disease Programme, UFIEC, Institute of Health Carlos III, 28220, MajadahondaMadrid, Spain.
Guillermo Solís-FernándezChronic Disease Programme, UFIEC, Institute of Health Carlos III, 28220, MajadahondaMadrid, Spain.
Rodrigo BarderasChronic Disease Programme, UFIEC, Institute of Health Carlos III, 28220, MajadahondaMadrid, Spain.
Susana CampuzanoDepartment of Analytical Chemistry, Faculty of Chemistry, Complutense University of Madrid, 28040, Madrid, Spain. susanacr@quim.ucm.es.ORCID http://orcid.org/0000-0002-9928-6613
Paloma Yáñez-SedeñoDepartment of Analytical Chemistry, Faculty of Chemistry, Complutense University of Madrid, 28040, Madrid, Spain. yseo@quim.ucm.es.
José M PingarrónDepartment of Analytical Chemistry, Faculty of Chemistry, Complutense University of Madrid, 28040, Madrid, Spain.
Universidad Complutense de Madrid · ESInstituto de Salud Carlos III · ES

Funding

AES-ISCIII PI17CIII/00045AES-ISCIII PI20CIII/00019Comunidad de Madrid S2018/NMT-4349Ministerio de Ciencia e Innovación PID2019-103899RB-I00Ministerio de Ciencia, Innovación y Universidades RTI2018-096135-B-I00
6 · The paper itself

Abstract

A dual immunosensor is reported for the simultaneous determination of two important immunity-related cytokines: BAFF (B cell activation factor) and APRIL (a proliferation-induced signal). Sandwich-type immunoassays with specific antibodies (cAbs) and a strategy for signal amplification based on labelling the detection antibodies (dAbs) with binary MoS

Indexed as

Biosensing TechniquesNanostructuresAntibodiesCell ProliferationCytokinesElectrochemical TechniquesHumansHydrogen PeroxideImmunoassayMolybdenumAntibodiesCytokinesHydrogen PeroxideMolybdenumAmperometryAPRILBAFFCRCDual immunoplatformMoS2/MWCNTsSerumSLE

Identifiers

PMID35286499
PMCPMC8921152
OpenAlexW4220781772

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.